Top Markets
Coin of the day
Bristol-Myers Squibb Company Bristol-Myers Squibb Company

Bristol-Myers Squibb Company

BMY
Κατάταξη σε μετοχές #174
Bristol-Myers Squibb Company operates as a global biopharmaceutical entity,... Bristol-Myers Squibb Company operates as a global biopharmaceutical entity, actively involved in the research, development, licensing, production, and worldwide commercialization of its medicinal portfolio. The company's therapeutic areas span hematology, oncology, cardiovascular health, immunology, fibrotic conditions, neuroscience, and infectious diseases like COVID-19. Its significant pharmaceutical offerings include Revlimid, an oral immunomodulatory agent for multiple myeloma, and Eliquis, an oral anticoagulant crucial for reducing stroke risk and systemic embolism in non-valvular atrial fibrillation, as well as treating deep vein thrombosis and pulmonary embolism. The portfolio also features Opdivo, utilized across various anti-cancer indications; Pomalyst/Imnovid, prescribed for multiple myeloma patients; and Orencia, targeting active rheumatoid arthritis and psoriatic arthritis in adults. Other key therapies are Sprycel, employed in the management of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy, indicated for patients with unresectable or metastatic melanoma; and Abraxane, a protein-bound chemotherapy formulation. Furthermore, Bristol-Myers Squibb offers Reblozyl, addressing anemia in adult patients with beta thalassemia; Empliciti, another treatment option for multiple myeloma; and Zeposia, designed to treat relapsing forms of multiple sclerosis. Revolutionary treatments like Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for adult patients battling relapsed or refractory large B-cell lymphoma, are also part of its lineup. Completing its product range are Inrebic, an oral kinase inhibitor specifically for adult myelofibrosis, and Onureg, used in the treatment of adult patients with acute myeloid leukemia (AML). Bristol-Myers Squibb distributes its pharmaceutical products through a diverse network encompassing wholesalers, distributors, pharmacies, retail outlets, hospitals, clinics, and governmental organizations. Founded in 1887 and formerly known as Bristol-Myers Company, the firm maintains its headquarters in New York, New York.
Τιμή μετοχής
$62.26
Τελευταίος συγχρονισμός: 2026-09-22
Κεφαλαιοποίηση
$127.18B
Αλλαγή (1 ημέρα)
-0.78%
Αλλαγή (1 έτος)
38.63%
Χώρα
US
Εμπόριο Bristol-Myers Squibb Company (BMY)

Κατηγορία

Ιστορικό μερισμάτων για Bristol-Myers Squibb Company (BMY)
Η μετοχή Bristol-Myers Squibb Company (σύμβολο: BMY) κατέβαλε συνολικά 214 μερίσματα.
Το συνολικό ποσό των μερισμάτων (προσαρμοσμένο για διασπάσεις μετοχών) είναι: $48.98
Απόδοση μερίσματος (TTM): 0.0392
Καταβολές μερισμάτων για Bristol-Myers Squibb Company (BMY) από 1972 έως 2026
Ετήσιες καταβολές μερισμάτων
Έτος Μέρισμα (προσαρμοσμένο για διασπάσεις μετοχών) Αλλαγή
2026 (TTM) $0.63 -74.60%
2025 $2.48 3.33%
2024 $2.40 5.26%
2023 $2.28 5.56%
2022 $2.16 46.94%
2021 $1.47 -35.81%
2020 $2.29 39.63%
2019 $1.64 2.50%
2018 $1.60 2.56%
2017 $1.56 36.84%
2016 $1.14 -23.49%
2015 $1.49 2.76%
2014 $1.45 -17.61%
2013 $1.76 29.41%
2012 $1.36 3.03%
2011 $1.32 37.50%
2010 $0.96 -23.20%
2009 $1.25 -19.35%
2008 $1.55 38.39%
2007 $1.12 0.00%
2006 $1.12 0.00%
2005 $1.12 33.33%
2004 $0.84 -25.00%
2003 $1.12 -20.00%
2002 $1.40 32.06%
2001 $1.06 13.65%
2000 $0.9328 13.84%
1999 $0.8194 47.16%
1998 $0.5568 -23.52%
1997 $0.728 -18.64%
1996 $0.8948 69.37%
1995 $0.5283 -39.34%
1994 $0.8709 27.10%
1993 $0.6852 39.10%
1992 $0.4926 -16.87%
1991 $0.5926 13.72%
1990 $0.5211 7.87%
1989 $0.4831 -6.85%
1988 $0.5186 107.52%
1987 $0.2499 16.72%
1986 $0.2141 -4.25%
1985 $0.2236 17.44%
1984 $0.1904 9.43%
1983 $0.174 43.80%
1982 $0.121 14.15%
1981 $0.106 48.46%
1980 $0.0714 -16.59%
1979 $0.0856 18.23%
1978 $0.0724 10.37%
1977 $0.0656 22.39%
1976 $0.0536 9.16%
1975 $0.0491 8.63%
1974 $0.0452 -6.03%
1973 $0.0481 170.22%
1972 $0.0178 0.00%
Λίστα όλων των καταβολών μερισμάτων
Έτος Μέρισμα Αλλαγή
2026 (TTM) $0.63 -74.60%
2025 $2.48 3.33%
2024 $2.40 5.26%
2023 $2.28 5.56%
2022 $2.16 46.94%
2021 $1.47 -35.81%
2020 $2.29 39.63%
2019 $1.64 2.50%
2018 $1.60 2.56%
2017 $1.56 36.84%
2016 $1.14 -23.49%
2015 $1.49 2.76%
2014 $1.45 -17.61%
2013 $1.76 29.41%
2012 $1.36 3.03%
2011 $1.32 37.50%
2010 $0.96 -23.20%
2009 $1.25 -19.35%
2008 $1.55 38.39%
2007 $1.12 0.00%
2006 $1.12 0.00%
2005 $1.12 33.33%
2004 $0.84 -25.00%
2003 $1.12 -20.00%
2002 $1.40 27.27%
2001 $1.10 12.24%
2000 $0.98 -8.84%
1999 $1.08 -8.12%
1998 $1.17 -23.53%
1997 $1.53 -59.31%
1996 $3.76 69.37%
1995 $2.22 -39.34%
1994 $3.66 27.08%
1993 $2.88 39.13%
1992 $2.07 -16.87%
1991 $2.49 13.70%
1990 $2.19 7.88%
1989 $2.03 -6.88%
1988 $2.18 55.71%
1987 $1.40 -22.22%
1986 $1.80 -4.26%
1985 $1.88 17.50%
1984 $1.60 -20.99%
1983 $2.03 -0.49%
1982 $2.04 14.33%
1981 $1.78 48.33%
1980 $1.20 -16.67%
1979 $1.44 18.03%
1978 $1.22 -11.27%
1977 $1.38 -23.61%
1976 $1.80 9.09%
1975 $1.65 8.55%
1974 $1.52 -6.17%
1973 $1.62 170.00%
1972 $0.6 0.00%
Καταβολές μερισμάτων για παρόμοιες εταιρείες ή ανταγωνιστές
Εταιρεία Αριθμός καταβολών μερισμάτων Χώρα
215.00%
US
225.00%
US
53.00%
US
33.00%
CH
223.00%
US